Best Agrolife Limited (NSE:BESTAGRO)

Longboard Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	16,763	18,143	18,733	17,457	12,108	9,054
Revenue	16,763	18,143	18,733	17,457	12,108	9,054
Revenue Growth (YoY)	-5.85%	-3.15%	7.31%	44.18%	33.72%	31.10%
Cost of Revenue	11,620	12,832	14,199	12,591	9,867	8,328
Gross Profit	5,143	5,311	4,535	4,866	2,241	726.05
Selling, General & Admin	1,064	1,073	944.39	572.59	264.17	112.89
Other Operating Expenses	2,165	2,236	1,279	956.84	312.32	101.08
Operating Expenses	3,662	3,737	2,550	1,774	694.86	243.49
Operating Income	1,482	1,574	1,985	3,092	1,547	482.57
Interest Expense	-637.7	-656.6	-589	-347.84	-116.17	-28.22
Interest & Investment Income	-	-	29.1	18.05	3.91	5.67
Currency Exchange Gain (Loss)	-	-	-55.3	-200.17	-6.75	62.74
Other Non Operating Income (Expenses)	56.5	45.8	-33.04	-39.61	-27.43	-19.15
EBT Excluding Unusual Items	900.5	962.9	1,337	2,522	1,400	503.61
Gain (Loss) on Sale of Investments	-	-	-	-	5.15	-0.3
Gain (Loss) on Sale of Assets	-	-	0.37	0.21	0.1	-
Other Unusual Items	-	-	-	6.6	1.26	4.55
Pretax Income	900.5	962.9	1,337	2,529	1,407	507.86
Income Tax Expense	215.1	264	274.28	607.51	358.98	137.1
Net Income	685.4	698.9	1,063	1,921	1,048	370.76
Net Income to Common	685.4	698.9	1,063	1,921	1,048	370.76
Net Income Growth	85.05%	-34.23%	-44.70%	83.41%	182.56%	348.70%
Shares Outstanding (Basic)	24	24	24	24	23	22
Shares Outstanding (Diluted)	24	24	24	24	23	22
Shares Change (YoY)	0.02%	0.01%	-	3.76%	3.41%	-
EPS (Basic)	28.98	29.56	44.95	81.28	45.98	16.83
EPS (Diluted)	28.98	29.56	44.94	81.26	45.98	16.83
EPS Growth	85.02%	-34.22%	-44.70%	76.73%	173.23%	348.75%
Free Cash Flow	-	2,074	-101.24	-2,176	-660.32	64.91
Free Cash Flow Per Share	-	87.73	-4.28	-92.06	-28.98	2.95
Dividend Per Share	-	3.000	3.000	3.000	2.000	2.000
Dividend Growth	-	-	-	50.00%	-	1900.00%
Gross Margin	30.68%	29.27%	24.21%	27.88%	18.51%	8.02%
Operating Margin	8.84%	8.67%	10.60%	17.71%	12.77%	5.33%
Profit Margin	4.09%	3.85%	5.67%	11.01%	8.65%	4.09%
Free Cash Flow Margin	-	11.43%	-0.54%	-12.47%	-5.45%	0.72%
EBITDA	1,944	2,002	2,280	3,312	1,648	503.04
EBITDA Margin	11.59%	11.04%	12.17%	18.97%	13.61%	5.56%
D&A For EBITDA	462.05	428.7	295.29	219.98	101.62	20.48
EBIT	1,482	1,574	1,985	3,092	1,547	482.57
EBIT Margin	8.84%	8.67%	10.60%	17.71%	12.77%	5.33%
Effective Tax Rate	23.89%	27.42%	20.52%	24.02%	25.52%	27.00%
Revenue as Reported	16,819	18,189	18,765	17,483	12,126	9,127
Advertising Expenses	-	-	91.11	68.73	19.22	7.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.